Diagnostics News and Research

RSS

VolitionRx's NuQ blood test receives CE Mark approval for detection of colorectal cancer

VolitionRx Limited today announced the Company's first CE Mark for its blood-based diagnostic assay, NuQ X001S, for detection of colorectal cancer. The NuQ test utilizes the Company's proprietary Nucleosomics technology platform, which identifies and analyses fragments of chromosomes, called nucleosomes, circulating within the blood for the presence of epigenetic cancer signals.

22 Sep 2015

Scientists uncover how embryonic stem cells inhibit virus expression

Scientists from the Institute of Molecular and Cell Biology, a research institute under the Agency for Science, Technology and Research, Singapore, have uncovered the mechanisms which embryonic stem cells employ to inhibit virus expression.

22 Sep 2015

Boehringer Ingelheim, BioMed X apply crowdsourcing approach to establish research team for identifying COPD treatment

Boehringer Ingelheim and BioMed X announced today that they have successfully applied a crowdsourcing approach to establish a research team of outstanding scientists from around the world with bright ideas, who will endeavor to identify new approaches for the treatment of patients with chronic obstructive pulmonary disease (COPD).

21 Sep 2015

Urinary tract infections could be treated more efficiently using DNA sequencing device

Urinary tract infections (UTIs) could be treated more quickly and efficiently using a DNA sequencing device the size of a USB stick - according to research from the University of East Anglia.

From Oxford Nanopore Technologies 21 Sep 2015

NYSCF, Q-State partner to advance precision medicine for nervous system disorders

The New York Stem Cell Foundation and Q-State Biosciences are partnering in a joint research collaboration to advance patient care for nervous system disorders through precision medicine. Through this collaboration, both organizations will further advance their respective technologies, while exploring how their proprietary research platforms might provide synergies in the process of developing novel therapeutics and companion diagnostics.

21 Sep 2015

CardioDx announces national agreement with Quest Diagnostics to expand access to Corus CAD blood test

CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, today announced a national specimen-draw agreement with Quest Diagnostics DGX, +1.23% the world's leading provider of diagnostic information services, that will expand patient and clinician access to the Corus CAD lab-developed blood test for aiding the assessment of obstructive coronary artery disease (CAD).

From Quest Diagnostics 18 Sep 2015

Technology enabling fewer invasive cardiac procedures benefits Glasgow children

Clinicians at Glasgow’s Royal Hospital for Sick Children are now able to scan patients’ hearts in just one heartbeat thanks to the installation of GE Healthcare’s Revolution* CT. The technology’s ability to freeze the heart’s motion helps to produce high quality diagnostic images, even for patients with erratic or high heart rates which may have led to poor quality images in the past. This helps reduce the need for invasive examination procedures and allows for quick and confident diagnoses of heart disease.

17 Sep 2015

Patient dedicated blood gas analyzer from Proxima showcased at NVIC Najaarscongres

Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will be exhibiting for the first time in The Netherlands its new patient dedicated arterial blood gas system. Attendees of the NVIC (Dutch Intensive Care Society) Najaarscongres 2015, in Utrecht from 17-18th September will be able to find out how the new Proxima System supports rapid and frequent measurements without leaving the patient’s bedside.

17 Sep 2015

Sphere Medical publishes white paper on blood conservation in critical care

Sphere Medical, innovator in critical care monitoring and diagnostics equipment, has published a white paper exploring the issues in critical care around anaemia, transfusions and blood conservation. Entitled ‘Blood conservation with a patient dedicated arterial blood gas analyser’, the new white paper is available for download from Sphere’s online clinical resource centre.

16 Sep 2015

Pipetting Solutions for Sample Screening

Our research focuses on interleukin 1 and the inflammasome and their role in innate immunity and inflammation.

From INTEGRA Biosciences 16 Sep 2015

WuXi NextCODE, CHFU partner to advance precision medicine in China

WuXi NextCODE, a precision medicine company using the genome to improve health worldwide, and the Children's Hospital of Fudan University, based in Shanghai and serving 2.3 million patients nationwide per year, today announced the signing of a landmark agreement for advancing precision medicine in China.

16 Sep 2015

HemoPalm technology can benefit physicians and first responders

Each year, hundreds of thousands of patients come to the ER experiencing life threatening events such as possible carbon monoxide poisoning or heart attacks, attending doctors in a medical institution rely on the current standard blood gas analyzers to diagnose the oxygen-carrying capabilities of blood, blood gases and electrolytes.

16 Sep 2015

GENFIT develops reliable, non-invasive diagnostic tool for NASH patients

GENFIT, a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions in metabolic and inflammatory diseases, that notably affect the liver or the gastrointestinal system, today announces the development of a new reliable and non-invasive diagnostic method, based on the measurement of a novel type of blood biomarker: small non-coding RNA, or miRNA.

16 Sep 2015

Benefits of reagent reservoirs video

A new short and engaging SimpleShow’ format video from INTEGRA introduces and explains the unique features and benefits of their Multichannel Pipette Reagent Reservoirs.

From INTEGRA Biosciences 16 Sep 2015

UCSF receives $5 million grant to create online database on all types of cancer

UC San Francisco has received a National Cancer Institute grant of $5 million over the next five years to lead a massive effort to integrate the data from all experimental models across all types of cancer.

16 Sep 2015

Cerilliant offers first-ever multi-component solutions for qualitative evaluation of drug interference

Sigma-Aldrich Corporation today announced that the Cerilliant® brand within its Applied Diagnostics and Testing business segment now offers the first-ever reference solutions for qualitative evaluation of drug interferences in a testing laboratory's analytical methods.

15 Sep 2015

Communicating risk status to at-risk Alzheimer's patients

How would you feel, as a cognitively healthy person, if a doctor said you had high odds of developing Alzheimer's disease within two to five years?

14 Sep 2015

Study shows WATS3D biopsy can help overcome limitations of histopathological assessment of esophageal precancer

Prevention of Esophageal Adenocarcinoma, the most rapidly growing cancer in the US and one of the most fatal, relies upon the detection of precancerous cells sampled during an endoscopy.

14 Sep 2015

nCounterRNA:Protein pancancer immune profiling panel launched by NanoString

NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced the commercial launch of the nCounter® RNA:Protein PanCancer Immune Profiling Panel

From NanoString Technologies 11 Sep 2015

Study shows half of adolescents misuse their prescription drugs

Although prescription drug misuse is on the decline among adolescents, one in two patients tested between the ages of 10 and 17 years are not using their medications appropriately, potentially putting their health at risk, according to an analysis by Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services.

From Quest Diagnostics 11 Sep 2015

Diagnostics News and Research

VolitionRx's NuQ blood test receives CE Mark approval for detection of colorectal cancer

Scientists uncover how embryonic stem cells inhibit virus expression

Boehringer Ingelheim, BioMed X apply crowdsourcing approach to establish research team for identifying COPD treatment

Urinary tract infections could be treated more efficiently using DNA sequencing device

NYSCF, Q-State partner to advance precision medicine for nervous system disorders

CardioDx announces national agreement with Quest Diagnostics to expand access to Corus CAD blood test

Technology enabling fewer invasive cardiac procedures benefits Glasgow children

Patient dedicated blood gas analyzer from Proxima showcased at NVIC Najaarscongres

Sphere Medical publishes white paper on blood conservation in critical care

Pipetting Solutions for Sample Screening

WuXi NextCODE, CHFU partner to advance precision medicine in China

HemoPalm technology can benefit physicians and first responders

GENFIT develops reliable, non-invasive diagnostic tool for NASH patients

Benefits of reagent reservoirs video

UCSF receives $5 million grant to create online database on all types of cancer

Cerilliant offers first-ever multi-component solutions for qualitative evaluation of drug interference

Communicating risk status to at-risk Alzheimer's patients

Study shows WATS3D biopsy can help overcome limitations of histopathological assessment of esophageal precancer

nCounterRNA:Protein pancancer immune profiling panel launched by NanoString

Study shows half of adolescents misuse their prescription drugs

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News